Artielle ImmunoTherapeutics Inc — Form D
Artielle ImmunoTherapeutics Inc of Tigard, OR, a company, filed a Form D exempt-offering notice with the SEC on 2010-04-13. The offering totals $700K, of which $186K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2010-04-13
- Form: D
- Accession: 0001298528-10-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $700K
- Amount sold: $186K
- Remaining: $514K
- Investors: 5
- Date of first sale: 2010-02-19
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-140451
Issuer
- Name: Artielle ImmunoTherapeutics Inc
- CIK: 0001298528
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 9020 SW Washington Square Road, Tigard, OR, 97223
- Phone: 503 626-1144
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Gilbert N Miller | Executive Officer | Tigard, OR |
| Shahab N Fatheazam | Director | Tigard, OR |
| Allan N Wolfe | Director | Salt Lake City, UT |
| J. Brock Metcalf | Director | Portland, OR |
| Adolph J Ferro | Director | Tigard, OR |
| Adolph J Ferro | Executive Officer | Tigard, OR |
| Paul N Quadros | Director | Burlingame, CA |
| Peter N McWilliams | Director | San Mateo, CA |
Other filings by this issuer (2)
More